419 related articles for article (PubMed ID: 16961428)
1. Mechanism of action of agents used in attention-deficit/hyperactivity disorder.
Wilens TE
J Clin Psychiatry; 2006; 67 Suppl 8():32-8. PubMed ID: 16961428
[TBL] [Abstract][Full Text] [Related]
2. A comparison of the efficacy of medications for adult attention-deficit/hyperactivity disorder using meta-analysis of effect sizes.
Faraone SV; Glatt SJ
J Clin Psychiatry; 2010 Jun; 71(6):754-63. PubMed ID: 20051220
[TBL] [Abstract][Full Text] [Related]
3. Drugs for treatment of ADHD.
Treat Guidel Med Lett; 2006 Nov; 4(51):77-82. PubMed ID: 17039210
[No Abstract] [Full Text] [Related]
4. Dopamine vs noradrenaline: inverted-U effects and ADHD theories.
Levy F
Aust N Z J Psychiatry; 2009 Feb; 43(2):101-8. PubMed ID: 19153917
[TBL] [Abstract][Full Text] [Related]
5. The role of alpha2-adrenergic agonists in attention-deficit/hyperactivity disorder.
Sallee FR
Postgrad Med; 2010 Sep; 122(5):78-87. PubMed ID: 20861591
[TBL] [Abstract][Full Text] [Related]
6. Attention-deficit-hyperactivity disorder: an update.
Dopheide JA; Pliszka SR
Pharmacotherapy; 2009 Jun; 29(6):656-79. PubMed ID: 19476419
[TBL] [Abstract][Full Text] [Related]
7. Nonstimulant therapies for attention-deficit hyperactivity disorder (ADHD) in children and adults.
Waxmonsky JG
Essent Psychopharmacol; 2005; 6(5):262-76. PubMed ID: 16222911
[TBL] [Abstract][Full Text] [Related]
8. Pharmacotherapy for child and adolescent attention-deficit hyperactivity disorder.
Kaplan G; Newcorn JH
Pediatr Clin North Am; 2011 Feb; 58(1):99-120, xi. PubMed ID: 21281851
[TBL] [Abstract][Full Text] [Related]
9. Mechanism of action of alpha 2A-adrenergic agonists in attention-deficit/hyperactivity disorder with or without oppositional symptoms.
Stahl SM
J Clin Psychiatry; 2010 Mar; 71(3):223-4. PubMed ID: 20331927
[No Abstract] [Full Text] [Related]
10. Treatment stabilization in children and adolescents with attention-deficit/hyperactivity disorder: data from the Netherlands.
Sasané R; Hodgkins P; Meijer W
Curr Med Res Opin; 2010 Nov; 26(11):2565-74. PubMed ID: 20863165
[TBL] [Abstract][Full Text] [Related]
11. Psychopharmacology of ADHD in adolescents.
Greydanus DE; Sloane MA; Rappley MD
Adolesc Med; 2002 Oct; 13(3):599-624. PubMed ID: 12270803
[TBL] [Abstract][Full Text] [Related]
12. Medications do not necessarily normalize cognition in ADHD patients.
Gualtieri CT; Johnson LG
J Atten Disord; 2008 Jan; 11(4):459-69. PubMed ID: 17934180
[TBL] [Abstract][Full Text] [Related]
13. Pharmacological management of attention-deficit hyperactivity disorder.
Reeves G; Schweitzer J
Expert Opin Pharmacother; 2004 Jun; 5(6):1313-20. PubMed ID: 15163276
[TBL] [Abstract][Full Text] [Related]
14. Dopamine transporter genotype influences the physiological response to medication in ADHD.
Gilbert DL; Wang Z; Sallee FR; Ridel KR; Merhar S; Zhang J; Lipps TD; White C; Badreldin N; Wassermann EM
Brain; 2006 Aug; 129(Pt 8):2038-46. PubMed ID: 16760197
[TBL] [Abstract][Full Text] [Related]
15. Evidence-based pharmacotherapy for attention-deficit hyperactivity disorder.
Biederman J; Spencer T; Wilens T
Int J Neuropsychopharmacol; 2004 Mar; 7(1):77-97. PubMed ID: 14733627
[TBL] [Abstract][Full Text] [Related]
16. The neuropharmacology of ADHD drugs in vivo: insights on efficacy and safety.
Heal DJ; Cheetham SC; Smith SL
Neuropharmacology; 2009 Dec; 57(7-8):608-18. PubMed ID: 19761781
[TBL] [Abstract][Full Text] [Related]
17. Advances in the treatment of attention-deficit/hyperactivity disorder: a guide for pediatric neurologists.
Wigal SB; Chae S; Patel A; Steinberg-Epstein R
Semin Pediatr Neurol; 2010 Dec; 17(4):230-6. PubMed ID: 21183129
[TBL] [Abstract][Full Text] [Related]
18. Treatment patterns, adherence, and persistence in ADHD: a Canadian perspective.
Lachaine J; Beauchemin C; Sasane R; Hodgkins PS
Postgrad Med; 2012 May; 124(3):139-48. PubMed ID: 22691908
[TBL] [Abstract][Full Text] [Related]
19. [Alternative agents used in ADHD].
Hässler F; Dück A; Reis O; Buchmann J
Z Kinder Jugendpsychiatr Psychother; 2009 Jan; 37(1):13-24, quiz 24-5. PubMed ID: 19105161
[TBL] [Abstract][Full Text] [Related]
20. Atomoxetine may improve methylphenidates' efficacy in treatment of ADHD?
Niederhofer H
Psychiatr Danub; 2009 Sep; 21(3):330. PubMed ID: 19794351
[No Abstract] [Full Text] [Related]
[Next] [New Search]
